BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for …PharmaLive (press release) (subscription)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing b…
USTR nominee asked about offshore investments – news9.com KWTV
|
USTR nominee asked about offshore investments
news9.com KWTV Who gets the next donated organ is a life or death matter, and now a judge is allowing two dying children in Pennsylvania to essentially jump the line. It’s an unprecedented challenge to the nation’s…More >>. It’s a life or death matter: Who gets the … |
Unusual antibodies in cows suggest new ways to make therapies for people – Science Codex
|
Unusual antibodies in cows suggest new ways to make therapies for people
Science Codex LA JOLLA, CA – June 6, 2013 – Humans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists from The Scripps Research Institute (TSRI) … |
10 Things to See: A week of top AP photos – KEYC TV
|
10 Things to See: A week of top AP photos
KEYC TV The organ transplant network has placed a dying 10-year-old girl on the adult waiting list for a donated lung, complying with a judge’s unusual order. The organ transplant network has placed a dying 10-year-old girl on the … This week’s collection … |
Cow antibodies may treat human diseases – U-T San Diego
|
Cow antibodies may treat human diseases
U-T San Diego LA JOLLA — Antibodies from cows may provide a new source of drugs for human diseases such as AIDS, according to a study led by Scripps Research Institute scientists. Bovines produce unusual antibodies that are very efficient in grabbing onto molecular … Unusual Antibodies in Cows Suggest New Ways to Make Therapies for PeopleNewswise (press release) Fabrus Scientists’ Work Published in Journal CellMarketWatch (press release) |
Fabrus Scientists' Work Published in Journal Cell – MarketWatch (press release)
|
Fabrus Scientists’ Work Published in Journal Cell
MarketWatch (press release) LA JOLLA, Calif., June 6, 2013 /PRNewswire via COMTEX/ — Fabrus Inc., a company developing a next-generation antibody discovery platform that expands the therapeutic applications of antibodies, today announced the publication of data in the journal … |
Cowen Questions Sales Growth Of Biogen Idec's MS Drug Tecfidera – Seeking Alpha
|
Cowen Questions Sales Growth Of Biogen Idec’s MS Drug Tecfidera
Seeking Alpha AVONEX® (interferon beta-1a), TYSABRI® (natalizumab) and RITUXAN® (rituximab) are Biogen’s other primary drugs in the MS indication. These three brought in the vast majority of the company’s $1.4 B in quarterly revenues ($736 million, $275 million and … |
Interior allows more comments for drilling rule – WBTV
|
Interior allows more comments for drilling rule
WBTV Who gets the next donated organ is a life or death matter, and now a judge is allowing two dying children in Pennsylvania to essentially jump the line. It’s an unprecedented challenge to the nation’s…More >>. It’s a life or death matter: Who gets the … |
Beta-blockers are good for patients with heart failure – Toronto NewsFIX
Toronto NewsFIX |
Beta-blockers are good for patients with heart failure
Toronto NewsFIX Some doctors feel that beta-blockers shouldn’t be used to treat patients with heart failure, because of concern over adverse effects. Yet research has suggested that beta-blockers may offer a survival advantage. To settle the question of whether beta … |
Needed: A conversation on organ donation – Philly.com (blog)
Philly.com (blog)Needed: A conversation on organ donationPhilly.com (blog)Organ donations from deceased donors resulted in the procurement of 28,600 organs that led to 24,560 transplants. … organs donated by consenting to be an organ donor (in Pennsy…